Global Mebeverine Market Growth 2020-2025
COVID-19, the disease it causes, surfaced in late 2019, and now had become a full-blown crisis worldwide. Over fifty key countries had declared a national emergency to combat coronavirus. With cases spreading, and the epicentre of the outbreak shifting to Europe, North America, India and Latin America, life in these regions has been upended the way it had been in Asia earlier in the developing crisis. As the coronavirus pandemic has worsened, the entertainment industry has been upended along with most every other facet of life. As experts work toward a better understanding, the world shudders in fear of the unknown, a worry that has rocked global financial markets, leading to daily volatility in the U.S. stock markets.
According to this latest study, the 2020 growth of Mebeverine will have significant change from previous year. By the most conservative estimates of global Mebeverine market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. We give this scenario a XX% probability, where under the scenario the supply chain will start to recover and quarantines and travel bans will ease, over the Q2. Longer-term, the effect of COVID-19 will be felt throughout the year with some degree of harm done by the virus. Over the next five years the Mebeverine market will register a XX% CAGR in terms of revenue, the global market size will reach US$ XX million by 2025.
This report presents a comprehensive overview, market shares, and growth opportunities of Mebeverine market by product type, application, key manufacturers and key regions and countries.
This study specially analyses the impact of Covid-19 outbreak on the Mebeverine, covering the supply chain analysis, impact assessment to the Mebeverine market size growth rate in several scenarios, and the measures to be undertaken by Mebeverine companies in response to the COVID-19 epidemic.
Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.
Capsule
Tablet
Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.
Hospital
Drug Store
On-line
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Abbott
Pharco
Mylan
Expanscience
Berlin Pharmaceutical
Greville Investing Limited
USV Private Limited
Eipico Pharmaceutical
Puren Pharma
Sopharma
Swiss Pharm
Aurovitas Pharma
Dr. Reddy's
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Mebeverine consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of Mebeverine market by identifying its various subsegments.
Focuses on the key global Mebeverine manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Mebeverine with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Mebeverine submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 What is the Impact of Covid-19 Outbreak On the Mebeverine?
1.8.1 Optimistic Scenario: COVID-19 Is Contained by May or June, with Normalcy Returning to Global Operations Through the End of Q2.
1.8.2 Conservative Scenario: COVID-19 Remains Prevalent, with Continued Impacts Lasting Into Q4.
1.8.3 Estimated Impact of the Coronavirus (COVID-19) Epidemic on the Global Mebeverine Market Size in 2020, by Scenario
1.8.4 Corporate Strategy the Manufacturers Should Be Thinking About Right Now
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Mebeverine Consumption 2015-2025
2.1.2 Mebeverine Consumption CAGR by Region
2.2 Mebeverine Segment by Type
2.2.1 Capsule
2.2.2 Tablet
2.3 Mebeverine Consumption by Type
2.3.1 Global Mebeverine Consumption Market Share by Type (2015-2020)
2.3.2 Global Mebeverine Revenue and Market Share by Type (2015-2020)
2.3.3 Global Mebeverine Sale Price by Type (2015-2020)
2.4 Mebeverine Segment by Application
2.4.1 Hospital
2.4.2 Drug Store
2.4.3 On-line
2.5 Mebeverine Consumption by Application
2.5.1 Global Mebeverine Consumption Market Share by Type (2015-2020)
2.5.2 Global Mebeverine Value and Market Share by Type (2015-2020)
2.5.3 Global Mebeverine Sale Price by Type (2015-2020)
3 Global Mebeverine by Company
3.1 Global Mebeverine Sales Market Share by Company
3.1.1 Global Mebeverine Sales by Company (2018-2020)
3.1.2 Global Mebeverine Sales Market Share by Company (2018-2020)
3.2 Global Mebeverine Revenue Market Share by Company
3.2.1 Global Mebeverine Revenue by Company (2018-2020)
3.2.2 Global Mebeverine Revenue Market Share by Company (2018-2020)
3.3 Global Mebeverine Sale Price by Company
3.4 Global Mebeverine Manufacturing Base Distribution, Sales Area, Type by Company
3.4.1 Global Mebeverine Manufacturing Base Distribution and Sales Area by Company
3.4.2 Players Mebeverine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Mebeverine by Regions
4.1 Mebeverine by Regions
4.2 Americas Mebeverine Consumption Growth
4.3 APAC Mebeverine Consumption Growth
4.4 Europe Mebeverine Consumption Growth
4.5 Middle East & Africa Mebeverine Consumption Growth
5 Americas
5.1 Americas Mebeverine Consumption by Countries
5.1.1 Americas Mebeverine Consumption by Countries (2015-2020)
5.1.2 Americas Mebeverine Value by Countries (2015-2020)
5.2 Americas Mebeverine Consumption by Type
5.3 Americas Mebeverine Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Mebeverine Consumption by Regions
6.1.1 APAC Mebeverine Consumption by Regions (2015-2020)
6.1.2 APAC Mebeverine Value by Regions (2015-2020)
6.2 APAC Mebeverine Consumption by Type
6.3 APAC Mebeverine Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions
7 Europe
7.1 Europe Mebeverine by Countries
7.1.1 Europe Mebeverine Consumption by Countries (2015-2020)
7.1.2 Europe Mebeverine Value by Countries (2015-2020)
7.2 Europe Mebeverine Consumption by Type
7.3 Europe Mebeverine Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Mebeverine by Countries
8.1.1 Middle East & Africa Mebeverine Consumption by Countries (2015-2020)
8.1.2 Middle East & Africa Mebeverine Value by Countries (2015-2020)
8.2 Middle East & Africa Mebeverine Consumption by Type
8.3 Middle East & Africa Mebeverine Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Mebeverine Distributors
10.3 Mebeverine Customer
11 Global Mebeverine Market Forecast
11.1 Global Mebeverine Consumption Forecast (2021-2025)
11.2 Global Mebeverine Forecast by Regions
11.2.1 Global Mebeverine Forecast by Regions (2021-2025)
11.2.2 Global Mebeverine Value Forecast by Regions (2021-2025)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Mebeverine Forecast by Type
11.8 Global Mebeverine Forecast by Application
12 Key Players Analysis
12.1 Abbott
12.1.1 Company Information
12.1.2 Mebeverine Product Offered
12.1.3 Abbott Mebeverine Sales, Revenue, Price and Gross Margin (2018-2020)
12.1.4 Main Business Overview
12.1.5 Abbott Latest Developments
12.2 Pharco
12.2.1 Company Information
12.2.2 Mebeverine Product Offered
12.2.3 Pharco Mebeverine Sales, Revenue, Price and Gross Margin (2018-2020)
12.2.4 Main Business Overview
12.2.5 Pharco Latest Developments
12.3 Mylan
12.3.1 Company Information
12.3.2 Mebeverine Product Offered
12.3.3 Mylan Mebeverine Sales, Revenue, Price and Gross Margin (2018-2020)
12.3.4 Main Business Overview
12.3.5 Mylan Latest Developments
12.4 Expanscience
12.4.1 Company Information
12.4.2 Mebeverine Product Offered
12.4.3 Expanscience Mebeverine Sales, Revenue, Price and Gross Margin (2018-2020)
12.4.4 Main Business Overview
12.4.5 Expanscience Latest Developments
12.5 Berlin Pharmaceutical
12.5.1 Company Information
12.5.2 Mebeverine Product Offered
12.5.3 Berlin Pharmaceutical Mebeverine Sales, Revenue, Price and Gross Margin (2018-2020)
12.5.4 Main Business Overview
12.5.5 Berlin Pharmaceutical Latest Developments
12.6 Greville Investing Limited
12.6.1 Company Information
12.6.2 Mebeverine Product Offered
12.6.3 Greville Investing Limited Mebeverine Sales, Revenue, Price and Gross Margin (2018-2020)
12.6.4 Main Business Overview
12.6.5 Greville Investing Limited Latest Developments
12.7 USV Private Limited
12.7.1 Company Information
12.7.2 Mebeverine Product Offered
12.7.3 USV Private Limited Mebeverine Sales, Revenue, Price and Gross Margin (2018-2020)
12.7.4 Main Business Overview
12.7.5 USV Private Limited Latest Developments
12.8 Eipico Pharmaceutical
12.8.1 Company Information
12.8.2 Mebeverine Product Offered
12.8.3 Eipico Pharmaceutical Mebeverine Sales, Revenue, Price and Gross Margin (2018-2020)
12.8.4 Main Business Overview
12.8.5 Eipico Pharmaceutical Latest Developments
12.9 Puren Pharma
12.9.1 Company Information
12.9.2 Mebeverine Product Offered
12.9.3 Puren Pharma Mebeverine Sales, Revenue, Price and Gross Margin (2018-2020)
12.9.4 Main Business Overview
12.9.5 Puren Pharma Latest Developments
12.10 Sopharma
12.10.1 Company Information
12.10.2 Mebeverine Product Offered
12.10.3 Sopharma Mebeverine Sales, Revenue, Price and Gross Margin (2018-2020)
12.10.4 Main Business Overview
12.10.5 Sopharma Latest Developments
12.11 Swiss Pharm
12.11.1 Company Information
12.11.2 Mebeverine Product Offered
12.11.3 Swiss Pharm Mebeverine Sales, Revenue, Price and Gross Margin (2018-2020)
12.11.4 Main Business Overview
12.11.5 Swiss Pharm Latest Developments
12.12 Aurovitas Pharma
12.12.1 Company Information
12.12.2 Mebeverine Product Offered
12.12.3 Aurovitas Pharma Mebeverine Sales, Revenue, Price and Gross Margin (2018-2020)
12.12.4 Main Business Overview
12.12.5 Aurovitas Pharma Latest Developments
12.13 Dr. Reddy's
12.13.1 Company Information
12.13.2 Mebeverine Product Offered
12.13.3 Dr. Reddy's Mebeverine Sales, Revenue, Price and Gross Margin (2018-2020)
12.13.4 Main Business Overview
12.13.5 Dr. Reddy's Latest Developments
13 Research Findings and Conclusion
Tables and Figures
List of Tables
Table 1. Estimated Impact of the Coronavirus (COVID-19) Epidemic on the Global Mebeverine Market Size in 2020, by Scenario
Table 2. COVID-19: Measures to be Undertaken by Mebeverine Companies
Table 3. Research Methodology
Table 4. Data Source
Table 5. Mebeverine Consumption CAGR by Region 2015-2025 ($ Millions)
Table 6. Major Players of Capsule
Table 7. Major Players of Tablet
Table 8. Global Consumption Sales by Type (2015-2020)
Table 9. Global Mebeverine Consumption Market Share by Type (2015-2020)
Table 10. Global Mebeverine Revenue by Type (2015-2020) ($ million)
Table 11. Global Mebeverine Value Market Share by Type (2015-2020) ($ Millions)
Table 12. Global Mebeverine Sale Price by Type (2015-2020)
Table 13. Global Consumption Sales by Application (2015-2020)
Table 14. Global Mebeverine Consumption Market Share by Application (2015-2020)
Table 15. Global Mebeverine Value by Application (2015-2020)
Table 16. Global Mebeverine Value Market Share by Application (2015-2020)
Table 17. Global Mebeverine Sale Price by Application (2015-2020)
Table 18. Global Mebeverine Sales by Company (2017-2019) (K Units)
Table 19. Global Mebeverine Sales Market Share by Company (2017-2019)
Table 20. Global Mebeverine Revenue by Company (2017-2019) ($ Millions)
Table 21. Global Mebeverine Revenue Market Share by Company (2017-2019)
Table 22. Global Mebeverine Sale Price by Company (2017-2019)
Table 23. Global Mebeverine Manufacturing Base Distribution and Sales Area by Manufacturers
Table 24. Players Mebeverine Products Offered
Table 25. Mebeverine Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
Table 26. Global Mebeverine Consumption by Regions 2015-2020 (K Units)
Table 27. Global Mebeverine Consumption Market Share by Regions 2015-2020
Table 28. Global Mebeverine Value by Regions 2015-2020 ($ Millions)
Table 29. Global Mebeverine Value Market Share by Regions 2015-2020
Table 30. Americas Mebeverine Consumption by Countries (2015-2020) (K Units)
Table 31. Americas Mebeverine Consumption Market Share by Countries (2015-2020)
Table 32. Americas Mebeverine Value by Countries (2015-2020) ($ Millions)
Table 33. Americas Mebeverine Value Market Share by Countries (2015-2020)
Table 34. Americas Mebeverine Consumption by Type (2015-2020) (K Units)
Table 35. Americas Mebeverine Consumption Market Share by Type (2015-2020)
Table 36. Americas Mebeverine Consumption by Application (2015-2020) (K Units)
Table 37. Americas Mebeverine Consumption Market Share by Application (2015-2020)
Table 38. APAC Mebeverine Consumption by Countries (2015-2020) (K Units)
Table 39. APAC Mebeverine Consumption Market Share by Countries (2015-2020)
Table 40. APAC Mebeverine Value by Regions (2015-2020) ($ Millions)
Table 41. APAC Mebeverine Value Market Share by Regions (2015-2020)
Table 42. APAC Mebeverine Consumption by Type (2015-2020) (K Units)
Table 43. APAC Mebeverine Consumption Market Share by Type (2015-2020)
Table 44. APAC Mebeverine Consumption by Application (2015-2020) (K Units)
Table 45. APAC Mebeverine Consumption Market Share by Application (2015-2020)
Table 46. Europe Mebeverine Consumption by Countries (2015-2020) (K Units)
Table 47. Europe Mebeverine Consumption Market Share by Countries (2015-2020)
Table 48. Europe Mebeverine Value by Countries (2015-2020) ($ Millions)
Table 49. Europe Mebeverine Value Market Share by Countries (2015-2020)
Table 50. Europe Mebeverine Consumption by Type (2015-2020) (K Units)
Table 51. Europe Mebeverine Consumption Market Share by Type (2015-2020)
Table 52. Europe Mebeverine Consumption by Application (2015-2020) (K Units)
Table 53. Europe Mebeverine Consumption Market Share by Application (2015-2020)
Table 54. Middle East & Africa Mebeverine Consumption by Countries (2015-2020) (K Units)
Table 55. Middle East & Africa Mebeverine Consumption Market Share by Countries (2015-2020)
Table 56. Middle East & Africa Mebeverine Value by Countries (2015-2020) ($ Millions)
Table 57. Middle East & Africa Mebeverine Value Market Share by Countries (2015-2020)
Table 58. Middle East & Africa Mebeverine Consumption by Type (2015-2020) (K Units)
Table 59. Middle East & Africa Mebeverine Consumption Market Share by Type (2015-2020)
Table 60. Middle East & Africa Mebeverine Consumption by Application (2015-2020) (K Units)
Table 61. Middle East & Africa Mebeverine Consumption Market Share by Application (2015-2020)
Table 62. Mebeverine Distributors List
Table 63. Mebeverine Customer List
Table 64. Global Mebeverine Consumption Forecast by Countries (2021-2025) (K Units)
Table 65. Global Mebeverine Consumption Market Forecast by Regions
Table 66. Global Mebeverine Value Forecast by Countries (2021-2025) ($ Millions)
Table 67. Global Mebeverine Value Market Share Forecast by Regions
Table 68. Global Mebeverine Consumption Forecast by Type (2021-2025) (K Units)
Table 69. Global Mebeverine Consumption Market Share Forecast by Type (2021-2025)
Table 70. Global Mebeverine Value Forecast by Type (2021-2025) ($ Millions)
Table 71. Global Mebeverine Value Market Share Forecast by Type (2021-2025)
Table 72. Global Mebeverine Consumption Forecast by Application (2021-2025) (K Units)
Table 73. Global Mebeverine Consumption Market Share Forecast by Application (2021-2025)
Table 74. Global Mebeverine Value Forecast by Application (2021-2025) ($ Millions)
Table 75. Global Mebeverine Value Market Share Forecast by Application (2021-2025)
Table 76. Abbott Product Offered
Table 77. Abbott Mebeverine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 78. Abbott Main Business
Table 79. Abbott Latest Developments
Table 80. Abbott Basic Information, Company Total Revenue (in $ million), Mebeverine Manufacturing Base, Sales Area and Its Competitors
Table 81. Pharco Product Offered
Table 82. Pharco Mebeverine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 83. Pharco Main Business
Table 84. Pharco Latest Developments
Table 85. Pharco Basic Information, Company Total Revenue (in $ million), Mebeverine Manufacturing Base, Sales Area and Its Competitors
Table 86. Mylan Product Offered
Table 87. Mylan Mebeverine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 88. Mylan Main Business
Table 89. Mylan Latest Developments
Table 90. Mylan Basic Information, Company Total Revenue (in $ million), Mebeverine Manufacturing Base, Sales Area and Its Competitors
Table 91. Expanscience Product Offered
Table 92. Expanscience Mebeverine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 93. Expanscience Main Business
Table 94. Expanscience Latest Developments
Table 95. Expanscience Basic Information, Company Total Revenue (in $ million), Mebeverine Manufacturing Base, Sales Area and Its Competitors
Table 96. Berlin Pharmaceutical Product Offered
Table 97. Berlin Pharmaceutical Mebeverine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 98. Berlin Pharmaceutical Main Business
Table 99. Berlin Pharmaceutical Latest Developments
Table 100. Berlin Pharmaceutical Basic Information, Company Total Revenue (in $ million), Mebeverine Manufacturing Base, Sales Area and Its Competitors
Table 101. Greville Investing Limited Product Offered
Table 102. Greville Investing Limited Mebeverine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 103. Greville Investing Limited Main Business
Table 104. Greville Investing Limited Latest Developments
Table 105. Greville Investing Limited Basic Information, Company Total Revenue (in $ million), Mebeverine Manufacturing Base, Sales Area and Its Competitors
Table 106. USV Private Limited Product Offered
Table 107. USV Private Limited Basic Information, Company Total Revenue (in $ million), Mebeverine Manufacturing Base, Sales Area and Its Competitors
Table 108. USV Private Limited Main Business
Table 109. USV Private Limited Latest Developments
Table 110. USV Private Limited Mebeverine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 111. Eipico Pharmaceutical Product Offered
Table 112. Eipico Pharmaceutical Mebeverine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 113. Eipico Pharmaceutical Main Business
Table 114. Eipico Pharmaceutical Latest Developments
Table 115. Eipico Pharmaceutical Basic Information, Company Total Revenue (in $ million), Mebeverine Manufacturing Base, Sales Area and Its Competitors
Table 116. Puren Pharma Product Offered
Table 117. Puren Pharma Mebeverine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 118. Puren Pharma Main Business
Table 119. Puren Pharma Latest Developments
Table 120. Puren Pharma Basic Information, Company Total Revenue (in $ million), Mebeverine Manufacturing Base, Sales Area and Its Competitors
Table 121. Sopharma Product Offered
Table 122. Sopharma Mebeverine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 123. Sopharma Main Business
Table 124. Sopharma Latest Developments
Table 125. Sopharma Basic Information, Company Total Revenue (in $ million), Mebeverine Manufacturing Base, Sales Area and Its Competitors
Table 126. Swiss Pharm Product Offered
Table 127. Swiss Pharm Mebeverine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 128. Swiss Pharm Main Business
Table 129. Swiss Pharm Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 130. Swiss Pharm Latest Developments
Table 131. Aurovitas Pharma Product Offered
Table 132. Aurovitas Pharma Mebeverine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 133. Aurovitas Pharma Main Business
Table 134. Aurovitas Pharma Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 135. Aurovitas Pharma Latest Developments
Table 136. Dr. Reddy's Product Offered
Table 137. Dr. Reddy's Mebeverine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 138. Dr. Reddy's Main Business
Table 139. Dr. Reddy's Latest Developments
Table 140. Dr. Reddy's Basic Information, Manufacturing Base, Sales Area and Its Competitors
List of Figures
Figure 1. Picture of Mebeverine
Figure 2. Mebeverine Report Years Considered
Figure 3. Market Research Methodology
Figure 4. Global Mebeverine Consumption Growth Rate 2015-2025 (K Units)
Figure 5. Global Mebeverine Value Growth Rate 2015-2025 ($ Millions)
Figure 6. Product Picture of Capsule
Figure 7. Product Picture of Tablet
Figure 8. Global Mebeverine Consumption Market Share by Type (2015-2020)
Figure 9. Global Mebeverine Value Market Share by Type (2015-2020)
Figure 10. Mebeverine Consumed in Hospital
Figure 11. Global Mebeverine Market: Hospital (2015-2020) (K Units)
Figure 12. Global Mebeverine Market: Hospital (2015-2020) ($ Millions)
Figure 13. Mebeverine Consumed in Drug Store
Figure 14. Global Mebeverine Market: Drug Store (2015-2020) (K Units)
Figure 15. Global Mebeverine Market: Drug Store (2015-2020) ($ Millions)
Figure 16. Mebeverine Consumed in On-line
Figure 17. Global Mebeverine Market: On-line (2015-2020) (K Units)
Figure 18. Global Mebeverine Market: On-line (2015-2020) ($ Millions)
Figure 19. Global Mebeverine Consumption Market Share by Application (2015-2020)
Figure 20. Global Mebeverine Value Market Share by Application (2015-2020)
Figure 21. Global Mebeverine Sales Market Share by Company in 2017
Figure 22. Global Mebeverine Sales Market Share by Company in 2019
Figure 23. Global Mebeverine Revenue Market Share by Company in 2017
Figure 24. Global Mebeverine Revenue Market Share by Company in 2019
Figure 25. Global Mebeverine Sale Price by Company in 2019
Figure 26. Global Mebeverine Consumption Market Share by Regions 2015-2020
Figure 27. Global Mebeverine Value Market Share by Regions 2015-2020
Figure 28. Americas Mebeverine Consumption 2015-2020 (K Units)
Figure 29. Americas Mebeverine Value 2015-2020 ($ Millions)
Figure 30. APAC Mebeverine Consumption 2015-2020 (K Units)
Figure 31. APAC Mebeverine Value 2015-2020 ($ Millions)
Figure 32. Europe Mebeverine Consumption 2015-2020 (K Units)
Figure 33. Europe Mebeverine Value 2015-2020 ($ Millions)
Figure 34. Middle East & Africa Mebeverine Consumption 2015-2020 (K Units)
Figure 35. Middle East & Africa Mebeverine Value 2015-2020 ($ Millions)
Figure 36. Americas Mebeverine Consumption Market Share by Countries in 2019
Figure 37. Americas Mebeverine Value Market Share by Countries in 2019
Figure 38. Americas Mebeverine Consumption Market Share by Type in 2019
Figure 39. Americas Mebeverine Consumption Market Share by Application in 2019
Figure 40. United States Mebeverine Consumption Growth 2015-2020 (K Units)
Figure 41. United States Mebeverine Value Growth 2015-2020 ($ Millions)
Figure 42. Canada Mebeverine Consumption Growth 2015-2020 (K Units)
Figure 43. Canada Mebeverine Value Growth 2015-2020 ($ Millions)
Figure 44. Mexico Mebeverine Consumption Growth 2015-2020 (K Units)
Figure 45. Mexico Mebeverine Value Growth 2015-2020 ($ Millions)
Figure 46. APAC Mebeverine Consumption Market Share by Countries in 2019
Figure 47. APAC Mebeverine Value Market Share by Regions in 2019
Figure 48. APAC Mebeverine Consumption Market Share by Type in 2019
Figure 49. APAC Mebeverine Consumption Market Share by Application in 2019
Figure 50. China Mebeverine Consumption Growth 2015-2020 (K Units)
Figure 51. China Mebeverine Value Growth 2015-2020 ($ Millions)
Figure 52. Japan Mebeverine Consumption Growth 2015-2020 (K Units)
Figure 53. Japan Mebeverine Value Growth 2015-2020 ($ Millions)
Figure 54. Korea Mebeverine Consumption Growth 2015-2020 (K Units)
Figure 55. Korea Mebeverine Value Growth 2015-2020 ($ Millions)
Figure 56. Southeast Asia Mebeverine Consumption Growth 2015-2020 (K Units)
Figure 57. Southeast Asia Mebeverine Value Growth 2015-2020 ($ Millions)
Figure 58. India Mebeverine Consumption Growth 2015-2020 (K Units)
Figure 59. India Mebeverine Value Growth 2015-2020 ($ Millions)
Figure 60. Australia Mebeverine Consumption Growth 2015-2020 (K Units)
Figure 61. Australia Mebeverine Value Growth 2015-2020 ($ Millions)
Figure 62. Europe Mebeverine Consumption Market Share by Countries in 2019
Figure 63. Europe Mebeverine Value Market Share by Countries in 2019
Figure 64. Europe Mebeverine Consumption Market Share by Type in 2019
Figure 65. Europe Mebeverine Consumption Market Share by Application in 2019
Figure 66. Germany Mebeverine Consumption Growth 2015-2020 (K Units)
Figure 67. Germany Mebeverine Value Growth 2015-2020 ($ Millions)
Figure 68. France Mebeverine Consumption Growth 2015-2020 (K Units)
Figure 69. France Mebeverine Value Growth 2015-2020 ($ Millions)
Figure 70. UK Mebeverine Consumption Growth 2015-2020 (K Units)
Figure 71. UK Mebeverine Value Growth 2015-2020 ($ Millions)
Figure 72. Italy Mebeverine Consumption Growth 2015-2020 (K Units)
Figure 73. Italy Mebeverine Value Growth 2015-2020 ($ Millions)
Figure 74. Russia Mebeverine Consumption Growth 2015-2020 (K Units)
Figure 75. Russia Mebeverine Value Growth 2015-2020 ($ Millions)
Figure 76. Middle East & Africa Mebeverine Consumption Market Share by Countries in 2019
Figure 77. Middle East & Africa Mebeverine Value Market Share by Countries in 2019
Figure 78. Middle East & Africa Mebeverine Consumption Market Share by Type in 2019
Figure 79. Middle East & Africa Mebeverine Consumption Market Share by Application in 2019
Figure 80. Egypt Mebeverine Consumption Growth 2015-2020 (K Units)
Figure 81. Egypt Mebeverine Value Growth 2015-2020 ($ Millions)
Figure 82. South Africa Mebeverine Consumption Growth 2015-2020 (K Units)
Figure 83. South Africa Mebeverine Value Growth 2015-2020 ($ Millions)
Figure 84. Israel Mebeverine Consumption Growth 2015-2020 (K Units)
Figure 85. Israel Mebeverine Value Growth 2015-2020 ($ Millions)
Figure 86. Turkey Mebeverine Consumption Growth 2015-2020 (K Units)
Figure 87. Turkey Mebeverine Value Growth 2015-2020 ($ Millions)
Figure 88. GCC Countries Mebeverine Consumption Growth 2015-2020 (K Units)
Figure 89. GCC Countries Mebeverine Value Growth 2015-2020 ($ Millions)
Figure 90. Global Mebeverine Consumption Growth Rate Forecast (2021-2025) (K Units)
Figure 91. Global Mebeverine Value Growth Rate Forecast (2021-2025) ($ Millions)
Figure 92. Americas Mebeverine Consumption 2021-2025 (K Units)
Figure 93. Americas Mebeverine Value 2021-2025 ($ Millions)
Figure 94. APAC Mebeverine Consumption 2021-2025 (K Units)
Figure 95. APAC Mebeverine Value 2021-2025 ($ Millions)
Figure 96. Europe Mebeverine Consumption 2021-2025 (K Units)
Figure 97. Europe Mebeverine Value 2021-2025 ($ Millions)
Figure 98. Middle East & Africa Mebeverine Consumption 2021-2025 (K Units)
Figure 99. Middle East & Africa Mebeverine Value 2021-2025 ($ Millions)
Figure 100. United States Mebeverine Consumption 2021-2025 (K Units)
Figure 101. United States Mebeverine Value 2021-2025 ($ Millions)
Figure 102. Canada Mebeverine Consumption 2021-2025 (K Units)
Figure 103. Canada Mebeverine Value 2021-2025 ($ Millions)
Figure 104. Mexico Mebeverine Consumption 2021-2025 (K Units)
Figure 105. Mexico Mebeverine Value 2021-2025 ($ Millions)
Figure 106. Brazil Mebeverine Consumption 2021-2025 (K Units)
Figure 107. Brazil Mebeverine Value 2021-2025 ($ Millions)
Figure 108. China Mebeverine Consumption 2021-2025 (K Units)
Figure 109. China Mebeverine Value 2021-2025 ($ Millions)
Figure 110. Japan Mebeverine Consumption 2021-2025 (K Units)
Figure 111. Japan Mebeverine Value 2021-2025 ($ Millions)
Figure 112. Korea Mebeverine Consumption 2021-2025 (K Units)
Figure 113. Korea Mebeverine Value 2021-2025 ($ Millions)
Figure 114. Southeast Asia Mebeverine Consumption 2021-2025 (K Units)
Figure 115. Southeast Asia Mebeverine Value 2021-2025 ($ Millions)
Figure 116. India Mebeverine Consumption 2021-2025 (K Units)
Figure 117. India Mebeverine Value 2021-2025 ($ Millions)
Figure 118. Australia Mebeverine Consumption 2021-2025 (K Units)
Figure 119. Australia Mebeverine Value 2021-2025 ($ Millions)
Figure 120. Germany Mebeverine Consumption 2021-2025 (K Units)
Figure 121. Germany Mebeverine Value 2021-2025 ($ Millions)
Figure 122. France Mebeverine Consumption 2021-2025 (K Units)
Figure 123. France Mebeverine Value 2021-2025 ($ Millions)
Figure 124. UK Mebeverine Consumption 2021-2025 (K Units)
Figure 125. UK Mebeverine Value 2021-2025 ($ Millions)
Figure 126. Italy Mebeverine Consumption 2021-2025 (K Units)
Figure 127. Italy Mebeverine Value 2021-2025 ($ Millions)
Figure 128. Russia Mebeverine Consumption 2021-2025 (K Units)
Figure 129. Russia Mebeverine Value 2021-2025 ($ Millions)
Figure 130. Spain Mebeverine Consumption 2021-2025 (K Units)
Figure 131. Spain Mebeverine Value 2021-2025 ($ Millions)
Figure 132. Egypt Mebeverine Consumption 2021-2025 (K Units)
Figure 133. Egypt Mebeverine Value 2021-2025 ($ Millions)
Figure 134. South Africa Mebeverine Consumption 2021-2025 (K Units)
Figure 135. South Africa Mebeverine Value 2021-2025 ($ Millions)
Figure 136. Israel Mebeverine Consumption 2021-2025 (K Units)
Figure 137. Israel Mebeverine Value 2021-2025 ($ Millions)
Figure 138. Turkey Mebeverine Consumption 2021-2025 (K Units)
Figure 139. Turkey Mebeverine Value 2021-2025 ($ Millions)
Figure 140. GCC Countries Mebeverine Consumption 2021-2025 (K Units)
Figure 141. GCC Countries Mebeverine Value 2021-2025 ($ Millions)
Figure 142. Abbott Mebeverine Market Share (2018-2020)
Figure 143. Pharco Mebeverine Market Share (2018-2020)
Figure 144. Mylan Mebeverine Market Share (2018-2020)
Figure 145. Expanscience Mebeverine Market Share (2018-2020)
Figure 146. Berlin Pharmaceutical Mebeverine Market Share (2018-2020)
Figure 147. Greville Investing Limited Mebeverine Market Share (2018-2020)
Figure 148. USV Private Limited Mebeverine Market Share (2018-2020)
Figure 149. Eipico Pharmaceutical Mebeverine Market Share (2018-2020)
Figure 150. Puren Pharma Mebeverine Market Share (2018-2020)
Figure 151. Sopharma Mebeverine Market Share (2018-2020)
Figure 152. Swiss Pharm Mebeverine Market Share (2018-2020)
Figure 153. Aurovitas Pharma Mebeverine Market Share (2018-2020)
Figure 154. Dr. Reddy's Mebeverine Market Share (2018-2020)
Reason to Buy
- Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
- Highlights key business priorities in order to assist companies to realign their business strategies
- The segment that is expected to dominate the Pharma & Healthcare Market
- Regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets